Combination strategies for enhancing transdermal absorption of theophylline through shed snake skin

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue SUPPL 2, 2012, Pages 30-34

  Moghimipour, Eskandar ^a   Tabassi, Seyyed Abolghassem Sajjadi ^b   Kouchak, Maryam ^a   Varghaei, Hadi ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bile salts; Enhancer; Permeation; Skin; Theophylline

Indexed keywords

BILE SALT; DEOXYCHOLATE SODIUM; OLEIC ACID; TAUROGLYCOCHOLIC ACID; THEOPHYLLINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG ABSORPTION; DRUG FORMULATION; DRUG PENETRATION; IN VITRO STUDY; NONHUMAN; REACTION TIME; SKIN ABSORPTION; SKIN PENETRATION; SNAKE; SURFACE TENSION; VIPERA LABATINA;

EID: 84862740419     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ruben Bunag R. xPharm: The Comprehensive Pharmacology Reference, Elsevier Inc. (2008) 1-5.
2. Craane-van Hinsberg WHM, Verhoef JC, Bax LJ, Junginger HE and Boddé HE. Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin. Pharm. Res. (1995) 12:1506-1512.
3. Kuramoto M, Tanaka T, Makita H, Nakamura Y and Yata N. Characteristics of shed snake skin permeability to indomethacin and fatty alcohols. J. Pharm. Pharmacol. (1996) 48: 680-684.
4. Hirvonen J, Kontturi K, Murtomaki L, Paronen P and Urtti A. Transdermal iontophoresis of sotalol and salicylate; the effect of skin charge and penetration enhancers. J. Control. Release. (1993) 26: 109-117.
5. Turunen TM, Buyuktimkin S, Buyuktimkin N, Urtti A, Paronen P. and Rytting JH. Enhanced delivery of 5-fluorouracil through shed snake skin by two new transdermal penetration enhancers. Int. J. Pharm. (1993) 92: 89-95.
6. Suh H and Jun HW. Effectiveness and mode of action of isopropyl myristate as a permeation enhancer for naproxen through shed snake skin. J. Pharm. Pharmacol. (1996) 48: 812-816.
7. Itoh T, Xia J, Magavi R, Nishihata T and Rytting JH. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: comparison with human skin. Pharm. Res. (1990) 7:1042-1047.
8. Rigg PC and Barry BW. Shed snake skin and hairless mouse skin as model membranes for human skin during permeation studies. J. Invest. Dermatol. (1990) 94: 235-2409.
9. Harada K, Murakami T, Kawasaki E, Higashi Y, Yamamoto S and Yata N. In vitro permeability to salicylic acid of human, rodent and shed snake skin. J. Pharm. Pharmaco. (1993) 4: 414-418.
10. Takahashi K, Tamagawa S, Katagi T, Rytting JH, Nishihata T and Mizuno N. Percutaneous penetration of basic compounds through shed snake skin as a model membrane. J. Pharm. Pharmacol. (1993) 45, pp. 882-886
11. Williams AC and Barry BW. Penetration enhancers. Adv Drug Deliv Rev. (2004). 56(5):603-18.
12. Moghimipour E, Jalali A, Sajjadi Tabassi SA and Löbenberg R. The Enhancing Effect of Sodium Glycocholate and Sodium Salicylate on Rats Gastro-intestinal Permeability to Insulin, Iranian Journal of Pharmaceutical Research. (2004) 2: 87-91.
13. Takahashi K and Rytting JH. Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane. JPP. (2001) 53:789-94.
14. Moghimipour E, Sajjadi Tabassi SA, Ramazani M, Loebenberg R. Enhanced permeability of gentamicin sulfate through shed snake skin and liposomal membranes by different enhancers. Iranian Journal of Basic Medicinal Sciences. (2003) 6(1): 9-19.
15. Kirshnaiah YS, Satyanarayana V and karthikeyan RS. Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J Pharm Pharmaceut Sci. (2002) 5(2): 123-30.
16. Senel S and Hincal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Cont Rel. (2001) 72(1): 133-44.
17. Ogiso T, Iwaki M, Yoneda I, Horinouchi M and Yamashita K. Percutaneous absorption of elcatonin and hypocalcemic effect in rat. Chem Pharm Bull. (1991) 39:449-53.
18. Swarbrick J and Boylan JC. editors. Encyclopedia of pharmaceutical technology. 2nd ed. New York: Marcel Dekker. (2002) 1: 1-6, 20, 3:3127.
19. Obata Y, Utsumi S, Watanabe H, Suda M, Tokudome Y, Makoto Otsuka M and Takayama K. Infrared spectroscopic study of lipid interaction in stratum corneum treated with transdermal absorption enhancers. International Journal of Pharmaceutics (2010) 389: 18-23.
20. Ranade VV. Drug delivery systems. 6. Transdermal drug delivery. J Clin Phormacol. (1991) 31:401-18.
21. Hsieh DS. (ed.) Drug permeation enhancement theory and applications. Marcel Dekker, New York. (1994) 10, 27-31, 59-63, 149-69.
22. Ibrahim SA and Li SK. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. International Journal of Pharmaceutics, (2010) 383: 89-98.
23. Lee CK, Kitagawa K, Uchida T, Kim NS and Goto S. Transdermal delivery of theophylline using an ethanol / panasate 800-ethyl cellulose gel preparation. Biol Pharm Bull. (1995) 18(1): 176-80.
24. Martin A. Physical pharmacy. 4th ed. Lea and Febiger, Philadelphia. (1993) 148,371-76, 396.
25. Kushida K, Matsumura M, Ohshima T, Yoshikawa H, Takada K and Muranishi S. Application of calcium thioglycolate to improve transdermal delivery of theophylline in rats. Chem Pharm Bull. (1984) 32(1): 268-74.
26. Tarantino R, Bishop E, Chen FC, Iqbal K and Malick AW. N-methyl-2-pyrrolidone as a cosolvent: relationship of cosolvent effect with solute polarity and the presence of proton-donating groups on model drug compounds. J Pharm Sci. (1994) 83(9): 1213-6.
27. Kadir R, Stempler D, Liron Z and Cohen S. Delivery of theophylline into excised human skin from alkanoic acid solutions: a push-pull mechanism. J Pharm Sci. (1987) 76(10): 774-8.